Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Elias Xirouchakis & Sotirios D. Georgopoulos. (2022) Evaluating treatments with rifabutin and amoxicillin for eradication of Helicobacter pylori infection in adults: a systematic review. Expert Opinion on Pharmacotherapy 23:2, pages 201-210.
Read now
Read now
Sotirios Georgopoulos & Vasilios Papastergiou. (2021) An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection. Expert Opinion on Pharmacotherapy 22:6, pages 729-741.
Read now
Read now
Floriana Giorgio, Enzo Ierardi, Claudia Sorrentino, Mariabeatrice Principi, Michele Barone, Giuseppe Losurdo, Andrea Iannone, Antonio Giangaspero, Rosa Monno & Alfredo Di Leo. (2016) Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. Scandinavian Journal of Gastroenterology 51:12, pages 1429-1432.
Read now
Read now
Articles from other publishers (6)
He-Jian Zhang, Xue-Hui Zhang, Jie Liu, Lu-Ning Sun, Yi-Wen Shen, Chen Zhou, Hong-Wen Zhang, Li-Jun Xie, Juan Chen, Yun Liu & Yong-Qing Wang. (2020) Effects of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of proton pump inhibitors. Pharmacological Research 152, pages 104606.
Crossref
Crossref
Yi Song, Fengna Dou, Zhe Zhou, Ningmin Yang, Jing Zhong, Jie Pan, Qiqi Liu, Jianzhong Zhang & Shengqi Wang. (2018)
Microarray-Based Detection and Clinical Evaluation for
Helicobacter pylori
Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients
. BioMed Research International 2018, pages 1-12.
Crossref
Crossref
Pavimol Angsantikul, Soracha Thamphiwatana, Qiangzhe Zhang, Kevin Spiekermann, Jia Zhuang, Ronnie H. Fang, Weiwei Gao, Marygorret Obonyo & Liangfang Zhang. (2018)
Coating Nanoparticles with Gastric Epithelial Cell Membrane for Targeted Antibiotic Delivery against
Helicobacter pylori
Infection
. Advanced Therapeutics 1:2, pages 1800016.
Crossref
Crossref
Diogo Branquinho, Nuno Almeida, Carlos Gregório, José Eduardo Pina Cabral, Adriano Casela, Maria Manuel Donato & Luís Tomé. (2017) Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?. BMC Gastroenterology 17:1.
Crossref
Crossref
Sotirios D. Georgopoulos, Elias Xirouchakis, Beatrice Martinez-Gonzales, Evanthia Zampeli, Elias Grivas, Charikleia Spiliadi, Maria Sotiropoulou, Kalliopi Petraki, Kostantinos Zografos, Fotini Laoudi, Dionysios Sgouras, Andreas Mentis, Panagiotis Kasapidis & Spyros Michopoulos. (2016) Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. European Journal of Internal Medicine 32, pages 84-90.
Crossref
Crossref
Zhao-Chun Chi. (2016)
Update on prevention and treatment of
Helicobacter pylori
infection
. World Chinese Journal of Digestology 24:16, pages 2454-2462.
Crossref
Crossref